Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use

NCT06734741 is registered in ClinicalTrials.gov with InBios International, Inc. as lead sponsor.

NCT NCT06734741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06734741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use
Lead sponsor
InBios International, Inc.
Phase
Observational
Overall status
Completed
Start date
December 26, 2024
Completion date
May 19, 2025
Enrollment
899 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza a, influenza b